Review: SARS-CoV-2 vaccines: Status report

Home/Review: SARS-CoV-2 vaccines: Status report

Review: SARS-CoV-2 vaccines: Status report

Review: SARS-CoV-2 vaccines: Status report

This article discusses therapeutic and prophylactic interventions for SARS-CoV-2 with a focus on vaccine development and its challenges.

In brief, the authors believe that, even though vaccines are being rapidly developed, they will likely come too late to affect the first wave of a potential pandemic. However, they believe that lessons learned from handling this outbreak will allow us to be better prepared in the future, especially if additional waves occur later or in a post-pandemic scenario in which SARS-CoV-2 continues to circulate as a seasonal virus.

Specifically, they encourage us to invest in sufficient surveillance, appropriate vaccine candidates, and infrastructure that could rapidly develop vaccines for use in the global population quickly and effectively. They also propose well-developed emergency plans that would allow us to develop, test, produce, and distribute vaccines within weeks, not months or years.

|2020-04-29T08:56:42-04:00April 28th, 2020|COVID-19 Literature|0 Comments

About the Author: Erika Cheng

Erika Cheng

Get Involved with Indiana CTSI